FundedIQ
Biotechnology

Zosano Pharma: Funding, Investors & Team (Sep 2026)

Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.

zosanopharma.com LinkedIn Fremont, United States 51-100 employees
Biopharma Biotechnology Medical
Total raised
$15.4M
Rounds
1
Latest
Post-IPO Debt
Feb 2022

Zosano Pharma has raised $15.4M across 1 funding round on record, the most recent a Post-IPO Debt of $15.4M announced in Feb 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Zosano Pharma Company Profile and Key Stats

Total funding raised
$15.4M
across 1 round on record
Funding rounds on record
1
Latest funding round
Post-IPO Debt
$15.4M in Feb 2022
Employees
51-100
reported band
Headquarters
Fremont, United States

Latest funding round on record: Feb 2022.

Zosano Pharma Funding Rounds

Date
Round
Amount
Post-IPO Debt
$15.4M

Zosano Pharma Founders and Leadership Team

Name
Role
Contact
Steve Lo
CEO
Locked

Contact details for the Zosano Pharma team: 1 of 1 has an email address on file.

Start 14-day free trial →

Zosano Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Zosano Pharma's latest round of $15.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Zosano Pharma in Biotechnology and Fremont

Companies Similar to Zosano Pharma

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Zosano Pharma Funding FAQs

What does Zosano Pharma do?

Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.

How much funding has Zosano Pharma raised?

Zosano Pharma has raised $15.4M across 1 round on record. The most recent is a Post-IPO Debt of $15.4M announced in Feb 2022.

When did Zosano Pharma last raise funding?

Zosano Pharma's most recent funding round on record is a Post-IPO Debt of $15.4M, announced in Feb 2022.

Who is the CEO of Zosano Pharma?

Steve Lo is listed as CEO at Zosano Pharma.

Where is Zosano Pharma headquartered?

Zosano Pharma is based in Fremont, California, United States.

How many employees does Zosano Pharma have?

Zosano Pharma is in the 51-100 employee band.

How does Zosano Pharma's funding compare to other Biotechnology startups?

Zosano Pharma's latest round of $15.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Zosano Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zosano Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.